Fabiana Corsi-Zuelli

Profile photo of Fabiana Corsi-Zuelli
I am a Postdoctoral Research Fellow at the University of Oxford, working with Professor Rachel Upthegrove as part of the NIHR Oxford Health Biomedical Research Centre (Molecular Targets Theme). My current research focuses on cellular immunology and genomics and its relation to symptoms, environmental risk factors, and brain structure/function. My ultimate goal is to identify novel targets for personalised treatments in psychosis. I hold an MSc and a PhD in Neuroscience, with a focus on Immunopsychiatry, from the Ribeirão Preto Medical School, University of São Paulo, funded by the São Paulo Research Foundation (FAPESP). During my training, I completed research placements at King’s College London and at the University of Birmingham. My work has been recognised with early-career awards from leading international organisations, including the Society of Biological Psychiatry (SOBP), the Schizophrenia International Research Society (SIRS), the British Association for Psychopharmacology (BAP), the World Federation of Societies of Biological Psychiatry (WFSBP), the International Society of Psychoneuroendocrinology (ISPNE), the Psychoneuroimmunology Research Society (PNIRS, Elsevier Award), and most recently, the global USERN Prize.

Website

Follow me here –

What’s in the blood? Immune cell changes in schizophrenia

feat

Dr Fabiana Corsi-Zuelli discusses the differences in immune cell counts in patients with schizophrenia compared to controls; highlighting a recent meta-analysis by Dudeck et al. (2025) that reinforces the growing consensus that immune dysfunction plays a role in schizophrenia.

[read the full story...]

Cellular immune phenotypes of depression: a gateway to precision medicine 

national-cancer-institute-jeT_DE3esSI-unsplash

In her debut blog, Fabiana Corsi-Zuelli summarises a recent systematic review and meta-analysis investigating the role of peripheral immune cells in depression, with a focus on implications for future immunotherapy trials.

[read the full story...]